Needham Reiterates Buy on Boston Scientific, Maintains $61 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a 'Buy' rating on Boston Scientific (NYSE:BSX) and maintained a price target of $61.
September 11, 2023 | 9:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific's stock rating has been reiterated as 'Buy' by Needham analyst Mike Matson, with a maintained price target of $61.
The reiteration of a 'Buy' rating by a respected analyst like Mike Matson is a positive signal for investors. The maintained price target of $61 indicates that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100